Cargando…

Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients

Chronic hepatitis B virus (HBV) infection is a major cause of cirrhosis and hepatocellular carcinoma (HCC). Applying the same strategies for antiviral therapy and HCC surveillance to all chronic hepatitis B (CHB) patients would be a burden worldwide. To properly manage CHB patients, it is necessary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hye Won, Ahn, Sang Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2016
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055862/ https://www.ncbi.nlm.nih.gov/pubmed/27729738 http://dx.doi.org/10.3748/wjg.v22.i37.8314

Ejemplares similares

Prediction models for development of hepatocellular carcinoma in chronic hepatitis B patients
por: Guo, Jiang, et al.
Publicado: (2021)

Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
por: Demirtas, Coskun Ozer, et al.
Publicado: (2021)

Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma
por: Gnyawali, Bipul, et al.
Publicado: (2022)

Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure
por: Shinn, Brianna J, et al.
Publicado: (2019)

Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows
por: Guarino, Maria, et al.
Publicado: (2018)

Risk of hepatocellular carcinoma after hepatitis C virus cure
por: Luna-Cuadros, Maria Alejandra, et al.
Publicado: (2022)

The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
por: Lee, Hye Won, et al.
Publicado: (2021)

Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection
por: Irshad, Mohammad, et al.
Publicado: (2017)

Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals
por: Baumert, Thomas F., et al.
Publicado: (2017)

Discontinuation of antiviral therapy in chronic hepatitis B patients
por: Medas, Renato, et al.
Publicado: (2021)

Hepatitis B: Who should be treated?-managing patients with chronic hepatitis B during the immune-tolerant and immunoactive phases
por: Kawanaka, Miwa, et al.
Publicado: (2021)

Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
por: Meringer, Hadar, et al.
Publicado: (2019)

Targeted and immune therapies for hepatocellular carcinoma: Predictions for 2019 and beyond
por: Kudo, Masatoshi
Publicado: (2019)

Challenges in the discontinuation of chronic hepatitis B antiviral agents
por: Kaewdech, Apichat, et al.
Publicado: (2021)

Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
por: Lee, Jae Seung, et al.
Publicado: (2022)

Regulatory T cells and their associated factors in hepatocellular carcinoma development and therapy
por: Zhang, Chun-Ye, et al.
Publicado: (2022)

Hepatocellular carcinoma occurrence in DAA-treated hepatitis C virus patients: Correlated or incidental? A brief review
por: Gigi, Eleni, et al.
Publicado: (2018)

Will the collaboration of surgery and external radiotherapy open new avenues for hepatocellular carcinoma with portal vein thrombosis?
por: Choe, Jung Wan, et al.
Publicado: (2022)

Deep learning in hepatocellular carcinoma: Current status and future perspectives
por: Ahn, Joseph C, et al.
Publicado: (2021)

Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?
por: Marisi, Giorgia, et al.
Publicado: (2018)

Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease
por: Cassese, Gianluca, et al.
Publicado: (2022)

Antiviral treatment for chronic hepatitis B: Safety, effectiveness, and prognosis
por: Wu, Ya-Li, et al.
Publicado: (2019)

Chronic hepatitis B in pregnant women: Current trends and approaches
por: Belopolskaya, Maria, et al.
Publicado: (2021)

Chronic hepatitis B: New potential therapeutic drugs target
por: Leowattana, Wattana, et al.
Publicado: (2022)

Treatment for hepatocellular carcinoma with tumor thrombosis in the hepatic vein or inferior vena cava: A comprehensive review
por: Zhang, Zun-Yi, et al.
Publicado: (2021)

Update on hepatocellular carcinoma: Pathologists’ review
por: El Jabbour, Tony, et al.
Publicado: (2019)

Anatomical resection of hepatocellular carcinoma: A critical review of the procedure and its benefits on survival
por: Kang, Koo Jeong, et al.
Publicado: (2017)

Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A debate near the end
por: Muzica, Cristina Maria, et al.
Publicado: (2020)

Nutritional therapy for hepatocellular carcinoma
por: Ruiz-Margáin, Astrid, et al.
Publicado: (2021)

Immunotherapy for recurrent hepatocellular carcinoma
por: Bhatt, Ahan, et al.
Publicado: (2023)

Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy
por: Lee, Jae Seung, et al.
Publicado: (2021)

Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B
por: Shin, Haneulsaem, et al.
Publicado: (2019)

Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma
por: Takakura, Kazuki, et al.
Publicado: (2018)

A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels
por: Sinn, Dong Hyun, et al.
Publicado: (2017)

Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate
por: Kamal, Ahmed, et al.
Publicado: (2022)

Molecular therapy for the treatment of hepatocellular carcinoma
por: Greten, T F, et al.
Publicado: (2009)

Dimensions of hepatocellular carcinoma phenotypic diversity
por: Désert, Romain, et al.
Publicado: (2018)

Hepatocellular carcinoma – time to take the ticket
por: Mullath, Anju, et al.
Publicado: (2019)

Characterization of metabolic landscape in hepatocellular carcinoma
por: Wu, Jing, et al.
Publicado: (2021)

Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma
por: Russo, Edda, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0en29kvougtbne3e2ddao6l7ic